The question
Can altered gene-control marks in nearby tissue independently start cancer?
This is the specific idea being tested.
The Hypothesis Critic · A guide for everyone
Epigenetic Field Cancerization
Can altered gene-control marks in nearby tissue independently start cancer?
What you need to knowAltered gene-control marks can affect risk, but predicting cancer does not prove that the marks start it alone.Relative explanatory fit: Alternative ranked ahead
Why the alternative fits better: Gene-control changes can increase susceptibility, while genetic changes and tissue conditions help determine whether cancer develops.
Review summary
Claim assessed: Spontaneous promoter hypermethylation in morphologically normal epithelium independently initiates and sustains pre-neoplastic clonal field expansion and subsequent carcinogenesis.
Finding: The registered scope-matched gate SC5 gives Γ. SC2 and SC3 reach Ε in defined engineered or inflammatory settings, while SC1 and SC4 remain Β for causal inference from association. Weakest-link sensitivity is Β. Predictive value and causal contributions are retained without substituting for spontaneous independent field initiation.
Key points
- SC1: Aberrant DNA methylation is present in morphologically normal epithelium at elevated tumor risk. — HSEF Β, Moderate confidence.
- SC2: Targeted tumor-suppressor promoter hypermethylation raises spontaneous tumor incidence in vivo. — HSEF Ε, Moderate confidence.
- SC3: Chronic inflammation causally induces durable epithelial DNA methylation. — HSEF Ε, Moderate confidence.
- SC4: Methylation in normal mucosa predicts metachronous cancer. — HSEF Β, Moderate confidence.
- SC5: Spontaneous endogenous epimutations independently initiate and sustain clonal field expansion. — HSEF Γ, Moderate confidence.
Verdict and review details
- Evidence grade
- HSEF Γ — Mechanistically plausible, partial system support
- Confidence
- Moderate
- Framework
- HSEF v5.3
- Review date
- Literature cutoff
- Published
- Review attribution (recorded)
- Codex
Evidence scope: 63 primary reports; literature cutoff 2026-10-09; source examination UTC date 2026-10-09; bounded critical review, not exhaustive systematic review.
The grade applies to the stated claim. Model rankings and individual subclaim grades remain separate from the overall causal-evidence grade.
Full scientific assessment and references · Scorecard (JSON) · Review source (Markdown)
The result at a glance
Altered gene-control marks can affect risk, but predicting cancer does not prove that the marks start it alone.
Read the labels in this illustration
THE MAIN FINDING Widespread epigenetic changes can mark tissue at risk, but they are not established as the main driver. The idea Do widespread epigenetic changes in normal-looking tissue drive cancer? Marks spread in tissue Field defect forms Cancer driven Proposed chain — plausible, not established What fits better Best fit in this review Epigenetic changes plus genetic damage Tissue with epigenetic marks Cancer Epigenetic mark Genetic damage Marks alter risk; genes and environment also matter. Links are dashed. What remains uncertain Whether marks cause cancer or only mark risk How much each factor contributes Which marks could be targeted Evidence comes from cells, animals, and people — each setting carries different weight. Methylation and other marks can alter risk without being the decisive cause; genes and environment also matter. Conceptual illustration
Best fit in this review
Changed tissue becomes more vulnerable
Gene-control changes can increase susceptibility, while genetic changes and tissue conditions help determine whether cancer develops.
Evidence for the stated claim
Plausible, not established
A higher rank means a better fit to the evidence in this comparison. It does not prove every part of the leading explanation.
Which explanation fits?
Another explanation fits better.
A separate question from the causal evidence grade
How does this explanation compare with alternatives?
Alternative ranked aheadThe reviewed hypothesis ranks 4 among 5 models compared; 1 alternative model(s) hold first rank for this stated claim.
Claim under review: rank 4 among 5 compared models.
Leading explanation: Epigenetic predisposition cooperating with genetic and tissue-state events.
Position in this comparison: Between leading and last ranks.
The causal grade asks how well the stated causal claim is established. This comparison asks which of the assessed explanations fits the reviewed findings better. A leading explanation can remain unproven. Models can overlap or include the tested mechanism; an alternative ahead does not make that mechanism irrelevant. These ordinal ranks apply within this review; they do not measure the size of a difference or rank scientific strength across topics.
Read the labels in this illustration
TWO EXPLANATIONS, COMPARED A · The idea under review Do widespread epigenetic changes in normal-looking tissue drive cancer? Proposed chain Marks spread Field defect Cancer driven Each arrow is a proposal, not a proven step. Methylation and other marks can alter risk without being the decisive cause; genes and environment also matter. B · Leading explanation Epigenetic changes plus genetic damage Another explanation fits better Marks plus damage (proposed links are dashed) A better fit is not proof of every part of the explanation. These explanations can overlap. Conceptual illustration
Idea being tested · rank 4
Can altered gene-control marks in nearby tissue independently start cancer?
Plausible, not established for the stated claim.
Best fit in this review · rank 1
Changed tissue becomes more vulnerable
Gene-control changes can increase susceptibility, while genetic changes and tissue conditions help determine whether cancer develops.
These explanations can overlap. Ranking their fit to the evidence is separate from deciding how firmly a cause has been established.
See all the explanations compared
Rank 1: Epigenetic predisposition cooperating with genetic and tissue-state events — Methylation can alter fitness and tumor susceptibility while context and further changes determine malignancy.
Rank 2: Inflammatory induction with persistent epigenetic memory — Inflammatory exposure generates partly durable methylation and alters tissue risk.
Rank 3: Genetic initiation with epigenetic gatekeeping — Selected driver clones can recruit methylation programs or exploit pre-existing epigenetic states.
Rank 4: Spontaneous autonomous epigenetic cancer field — Normal acquired methylation independently starts and sustains a clonal cancer field.
Rank 5: Age and exposure-associated methylation drift — Methylation records accumulated age/exposure and tissue state without necessarily driving every lesion.
What this means
?
Plausible, not established
Altered gene-control marks can affect risk, but predicting cancer does not prove that the marks start it alone.
Evidence rating: Γ · Moderate confidence. How the evidence was assessed.
The important distinction
Gene-control changes can increase susceptibility, while genetic changes and tissue conditions help determine whether cancer develops.
Health and treatment
The registered scope-matched gate SC5 gives Γ. SC2 and SC3 reach Ε in defined engineered or inflammatory settings, while SC1 and SC4 remain Β for causal inference from association. Weakest-link sensitivity is Β. Predictive value and causal contributions are retained without substituting for spontaneous independent field initiation.
From an idea to an explanation
Seeing two things together does not prove one causes the other.
What is observed?
Look for the proposed factor and the outcome, in the people or systems covered by the claim.
What else explains it?
Changed tissue becomes more vulnerable. Gene-control changes can increase susceptibility, while genetic changes and tissue conditions help determine whether cancer develops.
What test tells them apart?
Follow changed tissue before cancer appears and test the marks separately from other risk factors.
What to test next
What evidence would make the answer clearer?
Read the labels in this illustration
WHAT WOULD MAKE THE ANSWER CLEARER A research question Map epigenetic marks across tissue and test whether changing them alters cancer onset. then then Change the proposed cause Proposed test Add or remove marks Leave marks unchanged Marks changed in one group only. Measure the relevant outcome Marks mapped across tissue Cancer onset Measured in both groups. Check the result independently First team measures Second team repeats An independent check of the result. Same measures, fresh eyes — no shared data until the end. Setting: cells, animals and people This storyboard shows the logic of a test. It does not show a result. The question is whether changing the marks changes cancer onset. Conceptual illustration
A useful next question
Follow changed tissue before cancer appears and test the marks separately from other risk factors.
Change the proposed cause
Check that the intended change really happened.
Measure the relevant outcome
Allow for other factors and compare with suitable controls.
Check whether it holds up
Look for independent confirmation and the limits of the effect.
These are questions for research, not a claim that the proposed studies have already succeeded.
Read the scientific study designs
Proposed tests: 1 test design(s) are registered in the scorecard.
In plain terms, researchers would change the proposed cause, check that it changed as intended, then measure a meaningful outcome while controlling plausible alternatives. The result should be able to support or count against the claim—not only show that a pathway exists.
Experiment 1: Registered boundary experiment
Study design: In a defined uninjured adult epithelial lineage, follow naturally arising promoter epimutant clones with joint genome/methylome profiling, then selectively reverse the candidate methylation while preserving DNA sequence and compare clone fitness and incident cancer with catalytic-dead and matched-expression rescue controls.
What would be measured: Native clone survival/expansion, suppressor expression, new driver acquisition and spontaneous cancer incidence
Important controls: Age/organ/exposure matching, cell-state and inflammation controls, off-target methylome/genome audit, selective reversal and matched restoration
Result that would support the claim: Methylation precedes and independently confers clonal expansion and cancer propensity; selective reversal removes the advantage and matched restoration returns it without cooperating genomic changes
Result that would count against it: Clone fitness follows driver mutations or inflammatory state, selective reversal leaves progression intact, or only engineered/cooperating contexts produce cancer
Explore the evidence
Read the complete scientific review.
Follow the studies, detailed comparisons and evidence ratings behind this guide.
Open the scientific review →